Basic Information
MEDIPOST is a South Korean stem cell therapy developer specializing in the research of umbilical cord blood immune cell treatments. MEDIPOST's mission is to help patients with incurable diseases address unmet medical needs through stem cells and regenerative medicine.
MEDIPOST Co., Ltd.
Seongnam,GyeonggiProvince,SouthKorea
unclear
--
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios